Ganciclovir Terminated Phase 2 Trials for EBV Lymphomas / Lympho-proliferative Diseases Treatment

IndicationsStatusPurposePhase
TerminatedTreatment2
clinicaltrials.gov IdentifierTitleDrugs
NCT00917826Study of Arginine Butyrate and Ganciclovir/Valganciclovir in EBV(+) Lymphoid Malignancies